← 返回

整合放射组学与单细胞转录组学揭示γδ T 细胞在肺腺癌中的关键作用

英文原题:Integrating of Radiomics and Single-cell Transcriptomics Uncovers the Crucial Role of γδ T Cells in Lung Adenocarcinoma.

查看英文原题

Integrating of Radiomics and Single-cell Transcriptomics Uncovers the Crucial Role of γδ T Cells in Lung Adenocarcinoma.

PubMed 2025/01/06(内容时间) J Cancer Q2 · IF 3.4(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

γδ T 细胞是肿瘤免疫微环境的重要组成部分,被认为是一种有前景的潜在治疗策略和靶点。越来越多的证据表明,这些独特的免疫细胞在多种癌症中发挥重要作用。然而,γδ T 细胞在肿瘤中常被认为具有双重作用,其对肺腺癌(LUAD)的影响仍存在争议。在本研究中,我们采用广泛的方法,利用多组学数据来探究 γδ T 细胞在 LUAD 中的功能。γδ T 细胞浸润丰度与肺腺癌的良好预后相关。γδ T 细胞的抑瘤作用通过内在谱系演化、获得细胞毒性功能以及与抗原呈递细胞进行信号转导来实现。此外,γδ T 细胞浸润丰度较高的患者可能更适合免疫治疗。最后,我们基于影像组学利用 CT 图像建立了一个预测模型,为评估 LUAD 患者中 γδ T 细胞浸润提供了一种非侵入性策略。这些发现为 γδ T 细胞的个性化治疗提供了新的见解和视角。

展开英文摘要原文

Gamma-delta (γδ) T cells are a crucial component of the tumor immune microenvironment which are considered a promising potential therapeutic strategy and target. Increasing evidence suggests that these unique immune cells play significant roles across various cancers.

However, γδ T cells are often regarded as having dual roles in tumors, and their influence on lung adenocarcinoma (LUAD) remains controversial. In this research, we employed a wild-ranging approach using multi-omics data to investigate the function of γδ T cells in LUAD. The abundance of γδ T cell infiltration is linked to a positive prognosis in lung adenocarcinoma. The tumor-inhibiting role of γδ T cells was played through intrinsic lineage evolution, acquiring cytotoxic functions and engaging in signal transduction with antigen-presenting cells.

Furthermore, patients with higher γδ T cells infiltration abundance might be more favorable for immunotherapy. Lastly, we established a predictive model using CT images based on radiomics, providing a non-invasive strategy to assess γδ T cells infiltration in LUAD patients.

These findings offer new insights and perspectives the personalized therapies of γδ T cells.

论文信息

作者
Chen Z、Yang C、Wang J、Wang B、He L、Liu Z、Li Y、Qin T
单位
Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.China
期刊
Journal of Cancer2025
原文标识
PubMed 39895781 · DOI 10.7150/jca.105586